• 简

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    A Look At Dentsply Sirona (XRAY) Valuation After Supportive Analyst Commentary On Growth Prospects

    Simply Wall St·01/08/2026 20:37:15
    语音播报

    Supportive analyst commentary has put fresh attention on DENTSPLY SIRONA (XRAY) after Barrington Research reiterated an upbeat rating tied to expectations for dental anesthesia market growth and rising procedure volumes, despite recent earnings and guidance pressure.

    See our latest analysis for DENTSPLY SIRONA.

    The recent analyst commentary comes after a sharp 7 day share price return of 8.22% and a 30 day share price return of 11.44%. However, the 1 year total shareholder return of negative 31.17% and 5 year total shareholder return of negative 76.79% show that, for longer term holders, momentum has been fading rather than building.

    If this move in dental equipment has caught your eye, it could be a good moment to compare DENTSPLY SIRONA with other healthcare stocks that might fit your watchlist next.

    With XRAY trading at $12.37, sitting close to analyst targets but also flagged with a value score of 5 and a large implied intrinsic discount, you have to ask: is this a genuine mispricing, or is future growth already baked in?

    Most Popular Narrative: 4% Undervalued

    Compared with XRAY's last close of US$12.37, the most followed narrative points to a fair value of about US$12.83, putting only a small gap between price and model.

    The analysts have a consensus price target of $16.857 for DENTSPLY SIRONA based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $24.0, and the most bearish reporting a price target of just $14.0.

    Read the complete narrative.

    What kind of earnings swing and margin reset does it take to back that fair value? The narrative leans on a sharp profit turnaround and a future earnings multiple well below many medical equipment peers. Curious how those moving parts fit together in the model?

    Result: Fair Value of $12.83 (UNDERVALUED)

    Have a read of the narrative in full and understand what's behind the forecasts.

    However, you also have to factor in weaker sales trends and tariff headwinds that are already pressuring margins and could make any earnings reset slower and more uneven.

    Find out about the key risks to this DENTSPLY SIRONA narrative.

    Build Your Own DENTSPLY SIRONA Narrative

    If you want to weigh the same data points yourself and come to your own conclusion, you can build a custom view of XRAY in just a few minutes, starting with Do it your way.

    A great starting point for your DENTSPLY SIRONA research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.

    Looking for more investment ideas?

    XRAY might be on your radar now, but you will widen your opportunity set if you regularly scan the market for fresh ideas that match your style.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.